Waqoo Hosts Investor Dialogues Post-Q2 Results; Highlights Medical Support Business Growth

TOKYO, Jun 22 (Pulse News Wire) – Waqoo Inc. (4937.T) hosted dialogues with institutional investors and asset managers post its fiscal 2026 second quarter results.

Key topics included the performance improvement in the medical support sector and strategic direction for direct-to-consumer (D2C) operations. CEO Fumihisa Sama presented the company’s growth strategy, emphasizing sustained profitability through optimized D2C investments and enhanced medical support services. Investors showed particular interest in the expansion potential of the medical support business, driven by partnerships and high utilization rates. During the discussions, management highlighted the importance of long-term value creation over short-term performance fluctuations.

Questions focused on the sustainability of revenue models, competitive advantages in the regenerative medicine field, and synergies with SBC Group. Management assured stakeholders that while some short-term volatility might occur due to ongoing investment, the overall structure supports higher profit margins moving forward. Feedback from investor meetings indicated a shift towards evaluating Waqoo based on its medical support business's long-term growth potential rather than immediate quarterly metrics. The company plans to enhance transparency around key performance indicators and strategic initiatives to align expectations with its evolving business model.